NCT05983250Phase 3Active not recruiting

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Study sponsor: Tenax Therapeutics, Inc. · TENX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-06-30Actual
Enrollment · participants230Estimated
Source updated2026-07-24Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: 16 Jun 2026. After: 30 Jun 2026.

Check registry source

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Oct 2026. After: 16 Jun 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview